ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs
August 18th 2022Sponsored in part by Daiichi Sankyo. Content independently developed by Oncology Nursing News®
A panel of experts in oncology review the use of antibody drug conjugates (ADCs) in breast and gastric cancers, defining optimal management of ADC-related adverse events.